Literature DB >> 2869259

Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project.

T J Anderson, J Lamb, F Alexander, W Lutz, U Chetty, A P Forrest, A Kirkpatrick, B Muir, M M Roberts, A Huggins.   

Abstract

In the Edinburgh Breast Screening Project 210 cancers were detected from commencement in 1979 up to December, 1984. By this time the full initial cohort had completed at least 3 visits and a proportion had attended for up to 5 visits, so pathological characteristics for prevalent and incident cancers could be compared. The main differences are in distribution of histological type of cancer, detection of occult invasive disease, and lymph-node positivity among incident tumours. Only the first of these was statistically significant. This evaluation shows that cancer detection by screening in Edinburgh conforms with screening theory, in which detection of good prognosis tumours is favoured at the prevalence screens, and faster growing, aggressive tumours are found at the incidence screens. Qualitative histopathology may provide a better measure than standard quantitative judgments of size and lymph node status to compare the varieties of cancer detected by screening programmes and to understand the biology of the disease.

Entities:  

Mesh:

Year:  1986        PMID: 2869259     DOI: 10.1016/s0140-6736(86)90882-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Knowledge-based computer system to aid in the histopathological diagnosis of breast disease.

Authors:  H Heathfield; D Bose; N Kirkham
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

2.  Risk factors for breast cancer with applications to selection for the prevalence screen.

Authors:  F E Alexander; M M Roberts; A Huggins
Journal:  J Epidemiol Community Health       Date:  1987-06       Impact factor: 3.710

3.  Influence of cancer histology on the success of fine needle aspiration of the breast.

Authors:  J Lamb; T J Anderson
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

4.  Role of fine needle aspiration cytology in breast cancer screening.

Authors:  J Lamb; T J Anderson; M J Dixon; P A Levack
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

5.  'Good prognosis tumours' in breast cancer screening.

Authors:  D Birch; M Payne; Y Chia; S McPherson
Journal:  Ann R Coll Surg Engl       Date:  1995-05       Impact factor: 1.891

Review 6.  Non-invasive breast carcinoma.

Authors:  M C Posner; N Wolmark
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Oestrogen receptor activity in breast cancer detected at a prevalence screening examination.

Authors:  M M Roberts; R A Hawkins; F E Alexander; T J Anderson; R J Steele
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

8.  Management of screen-detected breast cancer: audit of the first 100 cases in the Southampton and Salisbury breast screening programme.

Authors:  I Campbell; G Royle; R Coddington; A Herbert; C Rubin; I Taylor; P Guyer
Journal:  Ann R Coll Surg Engl       Date:  1993-01       Impact factor: 1.891

Review 9.  The biology and natural history of breast cancer from the screening perspective.

Authors:  L Holmberg; J Pontén; H O Adami
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

Review 10.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.